Author:
Walker Kevin,Croteau Rodney
Reference76 articles.
1. Paclitaxel is the generic name for Taxol which is a registered trademark of Bristol-Myers Squibb. Because of the greater familiarity with the word “Taxol”, we use it throughout.
2. WANI, M.C., TAYLOR, H.L., WALL, M.E., COGGON, P., MCPHAIL, A.T. 1971. Plant antitumor agents. VI. Isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93:2325–2327.
3. WALL, M.E., WANI, M.C. 1995. Paclitaxel: From discovery to clinic. In: Taxane Anticancer Agents: Basic Science and Current Status. ACS Symposium Series 583 (G.I. Georg, T.T. Chen, I. Ojima, D.M. Vyas., eds.) Washington, DC, pp. 18–30.
4. SCHIFF, P.B., FANT, J., HORWITZ, S.B. 1979. Promotion of microtubule assembly in vitro by Taxol. Nature 277:665–667.
5. KOWALSKI, R.J., GIANNAKAKOU, P., GUNASEKERA, S.P., LONGLEY, R.E., DAY, B.W., HAMEL, E. 1997. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Mol. Pharmacol. 52:613–622.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献